Cargando…
Application of lipid nanovesicle drug delivery system in cancer immunotherapy
Immunotherapy has gradually emerged as the most promising anticancer therapy. In addition to conventional anti-PD-1/PD-L1 therapy, anti-CTLA-4 therapy, CAR-T therapy, etc., immunotherapy can also be induced by stimulating the maturation of immune cells or inhibiting negative immune cells, regulating...
Autores principales: | Ding, Yinan, Wang, Luhong, Li, Han, Miao, Fengqin, Zhang, Zhiyuan, Hu, Chunmei, Yu, Weiping, Tang, Qiusha, Shao, Guoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073823/ https://www.ncbi.nlm.nih.gov/pubmed/35524277 http://dx.doi.org/10.1186/s12951-022-01429-2 |
Ejemplares similares
-
Lipid-like
Self-Assembling Peptide Nanovesicles for
Drug Delivery
por: Fatouros, Dimitrios G., et al.
Publicado: (2014) -
Smart Nanovesicles for Drug Targeting and Delivery
por: Marianecci, Carlotta, et al.
Publicado: (2019) -
Formulation and Evaluation of Guggul Lipid Nanovesicles for Transdermal Delivery of Aceclofenac
por: Gaur, Praveen Kumar, et al.
Publicado: (2014) -
Nanovesicles-Mediated Drug Delivery for Oral Bioavailability Enhancement
por: Ren, Yuehong, et al.
Publicado: (2022) -
Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy
por: Tong, Qing, et al.
Publicado: (2023)